Registration
WUXI BIOLOGICS USA LLC for WUXI BIOLOGICS USA LLC
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 7085 BIOSECURE ACT; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM AITCHISON New | — |
| ELIZABETH STEELE New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| WUXI BIOLOGICS IRELAND LIMITED | Ireland | Ireland | 100.0% | — |
| WUXI BIOLOGICS CO., LTD. | China | China | 100.0% | — |
| WUXI BIOLOGICS (CAYMAN) INC. | Cayman Islands | China | 100.0% | — |
| WUXI BIOLOGICS INVESTMENTS LIMITED | Hong Kong | China | 100.0% | — |
| WUXI BIOLOGICS (HONG KONG) LIMITED | Hong Kong | China | — | — |
| WUXI BIOLOGICS (SHANGHAI) CO., LTD | China | China | — | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.